Guidelines for the Management of Hypoglycaemia

 

Reviewed by Jane Harding
July
2004
Clinical Guidelines Back Newborn Services Home Page
Definition Diagnosis Treatment
Continuing Therapy References

Also see guideline on investigation of severe hypoglycaemia

Click here for the Glucose calculator

Hypoglycaemia is important because:

  1. It is a common, readily diagnosed and readily treated problem.
  2. If untreated, it may cause permanent brain damage.

Definition

Serum glucose <2.6mM.  This is based on the following:

  1. Glucose levels within the ‘normal’ range are not necessarily optimal.
  2. There is no physiological reason why brain glucose requirements should differ between term and preterm infants, or between the first and subsequent days of life.
  3. The aim is to define a level which is safe for all babies, rather than is adequate for most.
  4. Altered electrophysiological measurements and poor long-term neurological outcome have been reported in infants with recurrent serum glucose levels <2.6mM.

Diagnosis

  1. Monitor at-risk infants
  2. When to monitor
  3. How long to monitor
    • If feeding well
    At least 12 hours
    • Any recorded hypoglycaemia
    At least 12 hours after last low level

Click here to link to the flowchart for management of infants at risk of hypoglycaemia

Treatment

  1. All at risk infants (see above) should receive milk feedings (either breastfeed or formula - maternal preference) or intravenous dextrose as soon as feasible, and always within the first 2 hours of life.
  2. If glucose below 2.2mM on first testing (1-2 hours) 
        or 2.2-2.6mM after first 2 hours
    feed immediately and recheck glucose within 1 hour.
  3. If glucose below 2.2mM after first 2 hours
        or below 2.6mM on more than 2 occasions
        or feeds not tolerated 
  4. Recurrent or persistent hypoglycaemia not responding to above measures - increase IV dextrose concentration or volume e.g. 12.5 or 15% dextrose and continue feeding if tolerated.
  5. For small- or large-for-gestational age infants or infants of diabetic mothers on postnatal wards, see separate guidelines.

Continuing Therapy

Continue to monitor glucoses while IV dextrose is being gradually reduced. Rapid reductions in glucose infusion are likely to cause rebound hypoglycaemia.

Persistent or severe hypoglycaemia (requiring more than 10mg/kg/min of glucose or lasting longer than 1 week) may require further investigation and management, e.g. with glucagon, diazoxide, steroids or surgery.
Click here for the Glucose calculator

In an emergency, particularly if there is difficulty in starting intravenous glucose infusion, glucagon 100 to 300ug/kg intramuscularly will stabilise blood glucose in most babies for one to two hours. The dose can be repeated, but subsequent doses are much less likely to be effective. (Glucagon mobilises glycogen stores. After the first dose, stores will probably be depleted).

References

1 Koh THHG, Aynsley-Green A, Tarbit M, Eyre JA; Neural dysfunction during hypoglycaemia.  Arch Dis Child 1988; 63: 1353-1358.
2 Koh THHG, Eyre JA, Aynsley-Green A; Neonatal hypoglycaemia - the controversy regarding definition.  Arch Dis Child 1988; 63:1386-1398
3 LaFranchi S; Hypoglycaemia of infancy and childhood. Pediatric Clin N Amer 1987; 34(4): 961-80.
4 Lubchenco LO, Bard H; Incidence of hypoglycemia in newborn infants classified by birth weight and gestational age.  Pediatrics 1971; 47: 831-8.
5 Lucas A, Morley R, Cole TJ; Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia.  Br Med J 1971; 297: 1304-8.
6 Senior B, Sadeghi-Nejad A; Hypoglycemia: A pathophysiologic approach.  Acta Paediatr Scand Suppl 1989; 352: 1-27.
7 Glaser B, Thornton P, Otonkoski T, Junien C.  Genetics of neonatal hyperinsulinism.  Arch Dis Child Fetal Neonatal Ed 2000; 82:F79-F86.
8 Shepherd RM, Cosgrove KE, O'Brien RE, et al.  Hyperinsulinism of infancy: towards an understanding of unregulated insulin release.  Arch Dis Child Fetal Neonatal Ed 2000; 82:F87-F97.
9 Aynsley-Green A, Hussain K, Hall J, et al.  Practical management of hyperinsulinism in infancy.  Arch Dis Child Fetal Neonatal Ed 2000; 82:F98-F107.
10 Rahier J, Guiot Y, Sempoux C.  Persistent hyperinsulinaemic hypoglycaemia of infancy: a heterogenous syndrome unrelated to nesidioblastosis.  Arch Dis Child Fetal Neonatal Ed 2000; 82:F108-F112.